Biotricity Inc. announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists' patient use - Bioflux® and BiotresTM. The distribution agreement covers Bioflux and Biotres and will be distributed directly to hospitals and clinics for professional medical utilization with suitable patients.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | -0.84% | +7.27% | +2.61% |
04-26 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
04-19 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
+2.61% | 13.64M | |
+1.11% | 186M | |
-19.58% | 79.09M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. Signs Distribution Agreement with Top 5 Distributor for Its Cardiac Monitoring Solutions